<p>根据最近向美国证券交易委员会提交的 13F 表格，诺瓦斯科舍银行信托公司在第一季度将其在赛默飞世尔科技公司（NYSE:TMO - 免费报告）的持股增加了 26.2%。该机构投资者在季度内购买了 661 股后，持有该医疗研究公司 3,182 股股票。诺瓦斯科舍银行信托公司在赛默飞世尔科技的持股在最近一个季度末价值为 1,583,000 美元。</p>
<ul>
<li>现金流关注：赛默飞世尔、能源转移和网易</li>
</ul>
<p>其他一些对冲基金也增加或减少了在该公司的股份。J. Safra Sarasin Holding AG 在第一季度将其在赛默飞世尔科技的持股增加了 2.5%。J. Safra Sarasin Holding AG 目前持有 35,255 股该医疗研究公司的股票，价值为 17,544,000 美元，此前在上个季度购买了 844 股。马拉加湾资本有限责任公司在第一季度将其在赛默飞世尔科技的股份增加了 44.7%。马拉加湾资本有限责任公司目前持有 2,492 股该医疗研究公司的股票，价值为 1,240,000 美元，此前在此期间又收购了 770 股。Pathway Financial Advisers LLC 在第一季度将其在赛默飞世尔科技的股份增加了 4.1%。Pathway Financial Advisers LLC 目前持有 1,385 股该医疗研究公司的股票，价值为 689,000 美元，此前在此期间又收购了 55 股。桑坦德银行（Banco Santander S.A.）在第一季度将其在赛默飞世尔科技的股份增加了 14.0%。桑坦德银行目前持有 87,286 股该医疗研究公司的股票，价值为 43,434,000 美元，此前在此期间又收购了 10,714 股。最后，United Super Pty Ltd 作为建筑与建筑工会养老金基金的受托人，在第一季度将其在赛默飞世尔科技的股份增加了 7.6%。United Super Pty Ltd 作为建筑与建筑工会养老金基金的受托人，目前持有 111,210 股该医疗研究公司的股票，价值为 55,338,000 美元，此前在此期间又收购了 7,814 股。目前 89.23% 的股票由机构投资者持有。</p>
<h2>分析师升级和降级</h2>
<p>TMO 成为多份研究报告的主题。华尔街 Zen 在周六的研究报告中将赛默飞世尔科技的评级从 “持有” 上调至 “买入”。罗伯特·W·贝尔德在 7 月 24 日的研究报告中将赛默飞世尔科技的目标价从 553.00 美元上调至 567.00 美元，并给予该公司 “跑赢大盘” 的评级。雷蒙德·詹姆斯金融在 7 月 24 日的研究报告中重申了 “跑赢大盘” 的评级，并对赛默飞世尔科技的股票设定了 535.00 美元的目标价（之前为 525.00 美元）。Evercore ISI 在 7 月 8 日的研究报告中将赛默飞世尔科技的目标价从 500.00 美元下调至 480.00 美元，并为该公司设定了 “跑赢大盘” 的评级。最后，富国银行将赛默飞世尔科技的目标价从 570.00 美元下调至 565.00 美元，并在 7 月 24 日的研究报告中对该股票设定了 “超配” 的评级。六位分析师对该股票给予了 “持有” 的评级，十六位分析师对该公司的股票给予了 “买入” 的评级。根据 MarketBeat.com 的数据，赛默飞世尔科技目前的平均评级为 “适度买入”，共识目标价为 593.00 美元。</p>
<ul>
<li>安捷伦科技受益于对持久性化学品的打击</li>
</ul>
<p><strong>获取我们关于赛默飞世尔科技的最新研究报告</strong></p>
<h2>赛默飞世尔科技股票下跌 1.1%</h2>
<p>TMO 股票在周五开盘价为 462.74 美元。该股票的 50 日简单移动平均线为 420.88 美元，200 日简单移动平均线为 467.66 美元。该公司的流动比率为 1.93，速动比率为 1.50，债务与股本比率为 0.65。赛默飞世尔科技公司的一年最低价为 385.46 美元，一年最高价为 627.88 美元。该股票的市值为 1746.8 亿美元，市盈率为 26.76，市盈增长比率为 2.50，贝塔值为 0.77。</p>
<ul>
<li>S&amp;P 500 中增长最快的四大股息：买入、卖出还是持有？</li>
</ul>
<p>赛默飞世尔科技（NYSE:TMO - 获取免费报告）最近在 7 月 23 日发布了季度财报。该医疗研究公司报告每股收益为 5.36 美元，超过了市场共识预期的 5.22 美元，超出 0.14 美元。赛默飞世尔科技的股本回报率为 16.82%，净利润率为 15.24%。该公司的季度收入为 108.6 亿美元，而分析师预期为 106.8 亿美元。在去年同期，该公司每股收益为 5.37 美元。该公司的收入同比增长了 2.9%。分析师预计赛默飞世尔科技公司今年将发布 23.28 美元的每股收益。</p>
<h2>赛默飞世尔科技分红公告</h2>
<p>该公司最近还宣布了一项季度分红，将于 10 月 15 日（星期三）支付。9 月 15 日（星期一）的股东将获得 0.43 美元的分红。除息日为 9 月 15 日（星期一）。这代表着每年 1.72 美元的分红和 0.4% 的分红收益率。赛默飞世尔科技的派息比率目前为 9.95%。</p>
<h2>内部活动</h2>
<p>在其他赛默飞世尔科技的新闻中，执行副总裁 Gianluca Pettiti 在 7 月 25 日（星期五）出售了 400 股公司的股票。该股票以 479.98 美元的平均价格出售，总价值为 191,992.00 美元。出售后，该执行副总裁直接持有公司 22,367 股股票，价值为 10,735,712.66 美元。此次交易使其持股减少了 1.76%。该出售在向美国证券交易委员会的备案中披露，相关信息可通过 SEC 网站获取。目前 0.33% 的股票由内部人士持有。</p>
<h2>赛默飞世尔科技简介</h2>
<p>（免费报告）</p>
<p>赛默飞世尔公司在北美、欧洲、亚太及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比赛默飞世尔更好的股票</li>
<li>如何计算投资回报率 (ROI)</li>
<li>Hims &amp; Hers 会跟随诺和诺德下跌吗？</li>
<li>最佳股票推荐：低于 $10.00</li>
<li>保持冷静：为什么 Comfort Systems USA 是一个隐藏的 AI 胜利者</li>
<li>什么是空头头寸？如何使用它</li>
<li>Rocket Lab 下周报告：投资者需要知道的事项</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在赛默飞世尔吗？</h2>
<p>在考虑赛默飞世尔之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前购买的股票……而赛默飞世尔并不在名单上。</p>
<p>虽然赛默飞世尔目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

赛默飞世尔

<p>加拿大新斯科舍银行信托公司在第一季度将其在赛默飞世尔（Thermo Fisher Scientific Inc.，NYSE:TMO）的持股增加了 26.2%，增持了 661 股，总持股达到 3,182 股，市值为 1,583,000 美元。其他机构投资者也提高了他们的持股比例。分析师已上调了 TMO 的评级，市场共识目标价为 593.00 美元。该股票开盘价为 462.74 美元，下跌 1.1%，市值为 1,746.8 亿美元。赛默飞世尔报告每股收益为 5.36 美元，超出预期，季度收入为 108.6 亿美元</p>

<p>Bank of Nova Scotia Trust Co. boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 26.2% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,182 shares of the medical research company's stock after purchasing an additional 661 shares during the quarter. Bank of Nova Scotia Trust Co.'s holdings in Thermo Fisher Scientific were worth $1,583,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>根据最近向美国证券交易委员会提交的 13F 表格，诺瓦斯科舍银行信托公司在第一季度将其在赛默飞世尔科技公司（NYSE:TMO - 免费报告）的持股增加了 26.2%。该机构投资者在季度内购买了 661 股后，持有该医疗研究公司 3,182 股股票。诺瓦斯科舍银行信托公司在赛默飞世尔科技的持股在最近一个季度末价值为 1,583,000 美元。</p>
</div><ul>
<li>Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase</li>
</ul>
<div class="lb-trans"><ul>
<li>现金流关注：赛默飞世尔、能源转移和网易</li>
</ul>
</div><p>A number of other hedge funds have also added to or reduced their stakes in the business. J. Safra Sarasin Holding AG increased its holdings in Thermo Fisher Scientific by 2.5% in the first quarter. J. Safra Sarasin Holding AG now owns 35,255 shares of the medical research company's stock worth $17,544,000 after purchasing an additional 844 shares in the last quarter. Malaga Cove Capital LLC grew its stake in Thermo Fisher Scientific by 44.7% in the first quarter. Malaga Cove Capital LLC now owns 2,492 shares of the medical research company's stock valued at $1,240,000 after acquiring an additional 770 shares during the period. Pathway Financial Advisers LLC grew its stake in Thermo Fisher Scientific by 4.1% in the first quarter. Pathway Financial Advisers LLC now owns 1,385 shares of the medical research company's stock valued at $689,000 after acquiring an additional 55 shares during the period. Banco Santander S.A. grew its stake in Thermo Fisher Scientific by 14.0% in the first quarter. Banco Santander S.A. now owns 87,286 shares of the medical research company's stock valued at $43,434,000 after acquiring an additional 10,714 shares during the period. Finally, United Super Pty Ltd in its capacity as Trustee for the Construction &amp; Building Unions Superannuation Fund grew its stake in Thermo Fisher Scientific by 7.6% in the first quarter. United Super Pty Ltd in its capacity as Trustee for the Construction &amp; Building Unions Superannuation Fund now owns 111,210 shares of the medical research company's stock valued at $55,338,000 after acquiring an additional 7,814 shares during the period. 89.23% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金也增加或减少了在该公司的股份。J. Safra Sarasin Holding AG 在第一季度将其在赛默飞世尔科技的持股增加了 2.5%。J. Safra Sarasin Holding AG 目前持有 35,255 股该医疗研究公司的股票，价值为 17,544,000 美元，此前在上个季度购买了 844 股。马拉加湾资本有限责任公司在第一季度将其在赛默飞世尔科技的股份增加了 44.7%。马拉加湾资本有限责任公司目前持有 2,492 股该医疗研究公司的股票，价值为 1,240,000 美元，此前在此期间又收购了 770 股。Pathway Financial Advisers LLC 在第一季度将其在赛默飞世尔科技的股份增加了 4.1%。Pathway Financial Advisers LLC 目前持有 1,385 股该医疗研究公司的股票，价值为 689,000 美元，此前在此期间又收购了 55 股。桑坦德银行（Banco Santander S.A.）在第一季度将其在赛默飞世尔科技的股份增加了 14.0%。桑坦德银行目前持有 87,286 股该医疗研究公司的股票，价值为 43,434,000 美元，此前在此期间又收购了 10,714 股。最后，United Super Pty Ltd 作为建筑与建筑工会养老金基金的受托人，在第一季度将其在赛默飞世尔科技的股份增加了 7.6%。United Super Pty Ltd 作为建筑与建筑工会养老金基金的受托人，目前持有 111,210 股该医疗研究公司的股票，价值为 55,338,000 美元，此前在此期间又收购了 7,814 股。目前 89.23% 的股票由机构投资者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>TMO has been the subject of a number of research reports. Wall Street Zen raised Thermo Fisher Scientific from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday. Robert W. Baird raised their price objective on Thermo Fisher Scientific from $553.00 to $567.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, July 24th. Raymond James Financial reissued an &#34;outperform&#34; rating and issued a $535.00 price objective (up previously from $525.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. Evercore ISI reduced their price objective on Thermo Fisher Scientific from $500.00 to $480.00 and set an &#34;outperform&#34; rating for the company in a research note on Tuesday, July 8th. Finally, Wells Fargo &amp; Company cut their target price on Thermo Fisher Scientific from $570.00 to $565.00 and set an &#34;overweight&#34; rating on the stock in a research report on Thursday, July 24th. Six analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat.com, Thermo Fisher Scientific presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $593.00.</p>
<div class="lb-trans"><p>TMO 成为多份研究报告的主题。华尔街 Zen 在周六的研究报告中将赛默飞世尔科技的评级从 “持有” 上调至 “买入”。罗伯特·W·贝尔德在 7 月 24 日的研究报告中将赛默飞世尔科技的目标价从 553.00 美元上调至 567.00 美元，并给予该公司 “跑赢大盘” 的评级。雷蒙德·詹姆斯金融在 7 月 24 日的研究报告中重申了 “跑赢大盘” 的评级，并对赛默飞世尔科技的股票设定了 535.00 美元的目标价（之前为 525.00 美元）。Evercore ISI 在 7 月 8 日的研究报告中将赛默飞世尔科技的目标价从 500.00 美元下调至 480.00 美元，并为该公司设定了 “跑赢大盘” 的评级。最后，富国银行将赛默飞世尔科技的目标价从 570.00 美元下调至 565.00 美元，并在 7 月 24 日的研究报告中对该股票设定了 “超配” 的评级。六位分析师对该股票给予了 “持有” 的评级，十六位分析师对该公司的股票给予了 “买入” 的评级。根据 MarketBeat.com 的数据，赛默飞世尔科技目前的平均评级为 “适度买入”，共识目标价为 593.00 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技受益于对持久性化学品的打击</li>
</ul>
</div><p><strong>Get Our Latest Research Report on Thermo Fisher Scientific</strong></p>
<div class="lb-trans"><p><strong>获取我们关于赛默飞世尔科技的最新研究报告</strong></p>
</div><h2>Thermo Fisher Scientific Stock Down 1.1%</h2>
<div class="lb-trans"><h2>赛默飞世尔科技股票下跌 1.1%</h2>
</div><p>TMO stock opened at $462.74 on Friday. The stock's fifty day simple moving average is $420.88 and its two-hundred day simple moving average is $467.66. The company has a current ratio of 1.93, a quick ratio of 1.50 and a debt-to-equity ratio of 0.65. Thermo Fisher Scientific Inc. has a 1-year low of $385.46 and a 1-year high of $627.88. The stock has a market cap of $174.68 billion, a P/E ratio of 26.76, a P/E/G ratio of 2.50 and a beta of 0.77.</p>
<div class="lb-trans"><p>TMO 股票在周五开盘价为 462.74 美元。该股票的 50 日简单移动平均线为 420.88 美元，200 日简单移动平均线为 467.66 美元。该公司的流动比率为 1.93，速动比率为 1.50，债务与股本比率为 0.65。赛默飞世尔科技公司的一年最低价为 385.46 美元，一年最高价为 627.88 美元。该股票的市值为 1746.8 亿美元，市盈率为 26.76，市盈增长比率为 2.50，贝塔值为 0.77。</p>
</div><ul>
<li>Top 4 Fastest Growing S&amp;P 500 Dividends: Buy, Sell, or Hold?</li>
</ul>
<div class="lb-trans"><ul>
<li>S&amp;P 500 中增长最快的四大股息：买入、卖出还是持有？</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.22 by $0.14. Thermo Fisher Scientific had a return on equity of 16.82% and a net margin of 15.24%. The business had revenue of $10.86 billion for the quarter, compared to analysts' expectations of $10.68 billion. During the same quarter in the previous year, the firm earned $5.37 earnings per share. The business's revenue was up 2.9% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.</p>
<div class="lb-trans"><p>赛默飞世尔科技（NYSE:TMO - 获取免费报告）最近在 7 月 23 日发布了季度财报。该医疗研究公司报告每股收益为 5.36 美元，超过了市场共识预期的 5.22 美元，超出 0.14 美元。赛默飞世尔科技的股本回报率为 16.82%，净利润率为 15.24%。该公司的季度收入为 108.6 亿美元，而分析师预期为 106.8 亿美元。在去年同期，该公司每股收益为 5.37 美元。该公司的收入同比增长了 2.9%。分析师预计赛默飞世尔科技公司今年将发布 23.28 美元的每股收益。</p>
</div><h2>Thermo Fisher Scientific Dividend Announcement</h2>
<div class="lb-trans"><h2>赛默飞世尔科技分红公告</h2>
</div><p>The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Monday, September 15th will be paid a $0.43 dividend. The ex-dividend date is Monday, September 15th. This represents a $1.72 annualized dividend and a dividend yield of 0.4%. Thermo Fisher Scientific's payout ratio is presently 9.95%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 10 月 15 日（星期三）支付。9 月 15 日（星期一）的股东将获得 0.43 美元的分红。除息日为 9 月 15 日（星期一）。这代表着每年 1.72 美元的分红和 0.4% 的分红收益率。赛默飞世尔科技的派息比率目前为 9.95%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 400 shares of the business's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $479.98, for a total value of $191,992.00. Following the sale, the executive vice president directly owned 22,367 shares in the company, valued at $10,735,712.66. The trade was a 1.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在其他赛默飞世尔科技的新闻中，执行副总裁 Gianluca Pettiti 在 7 月 25 日（星期五）出售了 400 股公司的股票。该股票以 479.98 美元的平均价格出售，总价值为 191,992.00 美元。出售后，该执行副总裁直接持有公司 22,367 股股票，价值为 10,735,712.66 美元。此次交易使其持股减少了 1.76%。该出售在向美国证券交易委员会的备案中披露，相关信息可通过 SEC 网站获取。目前 0.33% 的股票由内部人士持有。</p>
</div><h2>Thermo Fisher Scientific Profile</h2>
<div class="lb-trans"><h2>赛默飞世尔科技简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.</p>
<div class="lb-trans"><p>赛默飞世尔公司在北美、欧洲、亚太及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>How to Calculate Return on Investment (ROI)</li>
<li>Will Hims &amp; Hers Fall Along With Novo Nordisk?</li>
<li>Best Stocks Under $10.00</li>
<li>Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner</li>
<li>What is Short Interest? How to Use It</li>
<li>Rocket Lab Reports Next Week: Here’s What Investors Should Know</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比赛默飞世尔更好的股票</li>
<li>如何计算投资回报率 (ROI)</li>
<li>Hims &amp; Hers 会跟随诺和诺德下跌吗？</li>
<li>最佳股票推荐：低于 $10.00</li>
<li>保持冷静：为什么 Comfort Systems USA 是一个隐藏的 AI 胜利者</li>
<li>什么是空头头寸？如何使用它</li>
<li>Rocket Lab 下周报告：投资者需要知道的事项</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在赛默飞世尔吗？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑赛默飞世尔之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前购买的股票……而赛默飞世尔并不在名单上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然赛默飞世尔目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

加拿大丰业银行信托公司收购赛默飞世尔科技公司（NYSE:TMO）661 股股份